Cargando…
Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study
AIMS/INSTRUCTION: During the coronavirus disease 2019 (COVID‐19) pandemic, the lockdowns in Europe raised concerns about negative effects on glycemic control and body composition in patients with diabetes. In Japan, voluntary‐based restrictions were imposed as the declaration of a state of emergency...
Autores principales: | Tsukaguchi, Ryo, Murakami, Takaaki, Yoshiji, Satoshi, Shide, Kenichiro, Fujita, Yoshihito, Ogura, Masahito, Inagaki, Nobuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538039/ https://www.ncbi.nlm.nih.gov/pubmed/35980313 http://dx.doi.org/10.1111/jdi.13893 |
Ejemplares similares
-
Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study
por: Yasuda, Takuma, et al.
Publicado: (2021) -
LBODP001 Causal Associations Between Body Fat Accumulation and Covid-19 Severity: A Mendelian Randomization Study
por: Yoshiji, Satoshi, et al.
Publicado: (2022) -
Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
por: Fujita, Yoshihito, et al.
Publicado: (2019) -
Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors: A report of five cases
por: Yoshiji, Satoshi, et al.
Publicado: (2017) -
Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action
por: Fujita, Yoshihito, et al.
Publicado: (2014)